Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.

About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), ...

Redefine R&D with sophisticated cell-signaling peptides, which communicate directly with cellular receptors. See what it means for formulators.

Scientists have developed a way to engineer immune cells that specifically target tumors. The application of engineering ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...